Collegium Pharmaceutical, Inc. (COLL): Price and Financial Metrics


Collegium Pharmaceutical, Inc. (COLL): $20.44

0.05 (+0.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

COLL POWR Grades


  • COLL scores best on the Value dimension, with a Value rank ahead of 97.75% of US stocks.
  • The strongest trend for COLL is in Growth, which has been heading down over the past 48 weeks.
  • COLL's current lowest rank is in the Momentum metric (where it is better than 13.9% of US stocks).

COLL Stock Summary

  • With a one year PEG ratio of 1.63, Collegium Pharmaceutical Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 8.09% of US stocks.
  • With a price/earnings ratio of 6.79, Collegium Pharmaceutical Inc P/E ratio is greater than that of about just 10.42% of stocks in our set with positive earnings.
  • Over the past twelve months, COLL has reported earnings growth of 417.26%, putting it ahead of 94.25% of US stocks in our set.
  • Stocks that are quantitatively similar to COLL, based on their financial statements, market capitalization, and price volatility, are TTGT, STEP, SPWR, CHCI, and HCKT.
  • COLL's SEC filings can be seen here. And to visit Collegium Pharmaceutical Inc's official web site, go to www.collegiumpharma.com.

COLL Valuation Summary

  • In comparison to the median Healthcare stock, COLL's EV/EBIT ratio is 61.77% lower, now standing at 11.2.
  • Over the past 77 months, COLL's EV/EBIT ratio has gone up 25.6.
  • Over the past 77 months, COLL's price/earnings ratio has gone up 20.3.

Below are key valuation metrics over time for COLL.

Stock Date P/S P/B P/E EV/EBIT
COLL 2021-08-31 2.2 2.9 6.8 11.2
COLL 2021-08-30 2.2 2.9 6.8 11.1
COLL 2021-08-27 2.2 2.9 6.8 11.1
COLL 2021-08-26 2.3 2.9 6.9 11.2
COLL 2021-08-25 2.3 2.9 6.9 11.3
COLL 2021-08-24 2.2 2.9 6.8 11.2

COLL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • COLL has a Quality Grade of B, ranking ahead of 83.97% of graded US stocks.
  • COLL's asset turnover comes in at 0.493 -- ranking 88th of 677 Pharmaceutical Products stocks.
  • IRWD, IBIO, and MNKKQ are the stocks whose asset turnover ratios are most correlated with COLL.

The table below shows COLL's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.493 0.608 0.369
2021-03-31 0.498 0.612 0.422
2020-12-31 0.483 0.580 0.341
2020-09-30 0.552 0.522 0.367
2020-06-30 0.638 0.460 0.266
2020-03-31 0.772 0.391 2.336

COLL Price Target

For more insight on analysts targets of COLL, see our COLL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $26.71 Average Broker Recommendation 1.56 (Moderate Buy)

COLL Stock Price Chart Interactive Chart >

Price chart for COLL

COLL Price/Volume Stats

Current price $20.44 52-week high $26.91
Prev. close $20.39 52-week low $17.24
Day low $20.20 Volume 210,500
Day high $20.72 Avg. volume 387,765
50-day MA $21.44 Dividend yield N/A
200-day MA $22.57 Market Cap 726.93M

Collegium Pharmaceutical, Inc. (COLL) Company Bio


Collegium Pharmaceuticals is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx technology platform for the treatment of chronic pain and other diseases. The company was founded in 2002 and is based in Canton, Massachusetts.


COLL Latest News Stream


Event/Time News Detail
Loading, please wait...

COLL Latest Social Stream


Loading social stream, please wait...

View Full COLL Social Stream

Latest COLL News From Around the Web

Below are the latest news stories about Collegium Pharmaceutical Inc that investors may wish to consider to help them evaluate COLL as an investment opportunity.

COLL vs. ZTS: Which Stock Should Value Investors Buy Now?

COLL vs. ZTS: Which Stock Is the Better Value Option?

Yahoo | September 20, 2021

Top Pharmaceutical Stocks for Q4 2021

These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q4 2021.

Yahoo | September 14, 2021

Collegium Announces Four Posters Presented at PAINWeek 2021 National Conference

STOUGHTON, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that four poster presentations highlighting data regarding its product portfolio were presented at the Annual PAINWeek National Conference, which took place September 7-11, 2021 in Las Vegas, NV.

Intrado Digital Media | September 13, 2021

Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences during the month of September:

Intrado Digital Media | September 1, 2021

Collegium Announces $100 Million Share Repurchase Program

STOUGHTON, Mass., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that its Board of Directors has authorized the repurchase of up to $100 million of the Company’s shares of common stock. “Collegium is in a phase of growth and value creation, and this share repurchase program reflects our confidence in the underlying strength of our differentiated pain

Yahoo | August 16, 2021

Read More 'COLL' Stories Here

COLL Price Returns

1-mo 0.15%
3-mo -17.25%
6-mo -14.26%
1-year 10.55%
3-year 37.92%
5-year 24.71%
YTD 2.05%
2020 -2.67%
2019 19.86%
2018 -6.99%
2017 18.56%
2016 -43.38%

Continue Researching COLL

Here are a few links from around the web to help you further your research on Collegium Pharmaceutical Inc's stock as an investment opportunity:

Collegium Pharmaceutical Inc (COLL) Stock Price | Nasdaq
Collegium Pharmaceutical Inc (COLL) Stock Quote, History and News - Yahoo Finance
Collegium Pharmaceutical Inc (COLL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7978 seconds.